This holistic approach to supporting the whole body highlights the importance of NRF2 activation and shows why Petandim is an extremely valuable addition to your dog's daily regimen
Some peptides previously available through compounding pharmacies have been placed on the FDA's "do not compound" list
The STEP-1 trial (N=1,961) demonstrated that semaglutide 2.4 mg produced 14.9% mean body weight loss at 68 weeks versus 2.4% with placebo, providing the efficacy data that insurers reference in their coverage determinations 5
Limited research says no for GLP-1 pills and maybe for GLP-1 injections
When to seek urgent medical help: Whilst most gastrointestinal side effects are mild and self-limiting, participants and clinicians should be alert to the following red-flag symptoms, which require prompt medical assessment: Severe or persistent abdominal pain (which may indicate pancreatitis or gallbladder disease) Repeated vomiting or an inability to keep fluids down Signs of dehydration (such as dizziness, dark urine, or reduced urine output) Yellowing of the skin or eyes (jaundice) Anyone who suspects they have experienced a side effect from a medicine including medicines received as part of a clinical trial should report it via the MHRA Yellow Card scheme (yellowcard.mhra.gov.uk)
If you have any questions, contact us
